Ryan Nipp: Treatment Tolerability in Older Adults With Advanced Cancer
Ryan Nipp/ouhealth.com

Ryan Nipp: Treatment Tolerability in Older Adults With Advanced Cancer

Ryan Nipp, Oncologist and Cancer Outcomes Researcher at the University of Oklahoma, shared on X:

Treatment Tolerability in Older Adults With Advanced Cancer Receiving Geriatric Assessment-Guided Versus Oncologist-Guided Primary Treatment Modification: Secondary Analysis of the GAP70+ Trial.”

Title: Treatment Tolerability in Older Adults With Advanced Cancer Receiving Geriatric Assessment-Guided Versus Oncologist-Guided Primary Treatment Modification: Secondary Analysis of the GAP70+ Trial

Authors: Mostafa R. Mohamed,  David Q. Rich, Jennifer L. Lund, Christopher L. Seplaki,  Marie Flannery, Riham Alieldin, Yingzhu Chen, Erika Ramsdale, Allison Magnuson, Kah Poh Loh, Richard Dunne, Michelle Janelsins, Supriya Mohile.

Read the full article

Ryan Nipp

You can also read: ‘Population Aging and Cancer: Challenges and Opportunities in Geriatric Oncology

Geriatric oncology